301408 华人健康
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)6.4479.3296.9747.93318.565
总资产报酬率 ROA (%)2.4813.7102.9173.1917.071
投入资产回报率 ROIC (%)2.8824.2953.2973.5978.256

边际利润分析
销售毛利率 (%)34.71633.89532.61730.63932.575
营业利润率 (%)7.1505.4714.5884.0226.520
息税前利润/营业总收入 (%)7.6335.8595.0794.5007.278
净利润/营业总收入 (%)5.2543.8983.3603.0994.912

收益指标分析
经营活动净收益/利润总额(%)99.475126.231101.28192.52597.842
价值变动净收益/利润总额(%)0.8481.7070.7880.5310.378
营业外收支净额/利润总额(%)-0.832-1.968-1.194-0.8020.940

偿债能力分析
流动比率 (X)1.0801.0851.1921.4391.249
速动比率 (X)0.6800.6920.7961.0460.848
资产负债率 (%)60.24760.58757.32457.14163.240
带息债务/全部投入资本 (%)50.26750.81546.45245.34045.597
股东权益/带息债务 (%)89.80287.129103.399102.59394.517
股东权益/负债合计 (%)64.31763.06372.45473.75458.145
利息保障倍数 (X)14.09111.8769.3218.83010.459

营运能力分析
应收账款周转天数 (天)33.92633.46337.64345.50841.712
存货周转天数 (天)103.62695.21096.43390.01680.292